Spironolactone Tablet, Film Coated
Product Images NDC 71205-830

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 71205-830). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Spironolactone 01)

Structure (Spironolactone 01)
Chemical structure of spironolactone, showing the steroid ring framework with attached functional groups including a thioacetate and a lactone ring as characteristic elements.*
FDA Label Image

Figure 1 (Spironolactone 02)

Figure 1 (Spironolactone 02)
A Kaplan-Meier survival curve graph comparing the probability of an event over months between Spironolactone (n=822) and placebo (n=841) groups. The x-axis represents time in months up to 48 months, and the y-axis shows probability from 0 to 1. The Spironolactone group shows a lower probability curve than the placebo, with a statistically significant difference (log-rank p < 0.001).*
FDA Label Image

Figure 2 (Spironolactone 03)

Figure 2 (Spironolactone 03)
A forest plot chart showing hazard ratios (HR) and 95% confidence intervals (CI) comparing Spirnolactone to placebo across various subgroups including age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes, serum creatinine levels, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The chart visualizes the relative benefit of Spirnolactone versus placebo for each subgroup.*
FDA Label Image

71205-830-30 (Spironolactone 05)

71205-830-30 (Spironolactone 05)
This is a packaging label for Spironolactone 50 mg tablets, with 30 tablets per container. The label indicates film-coated, scored, white, round tablets with a debossed mark MP 542. Labeler is Proficient Rx LP, location Thousand Oaks, CA. Manufacturer is Frontida BioPharm, Inc., Philadelphia, PA. The label includes the NDC number 71205-830-30 and storage instructions at 20°-25°C (68°-77°F). It also features barcodes and QR codes for scanning.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.